Internal Medicine, Nephrology · Tucson, AZ
NPI
1467458919
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1645 N Swan Rd
Tucson, AZ, 85712
Phone (520) 623-2642
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
6,104 services
Medicare patients, 2024
626
Average age 76
Drug cost, 2024
$342K
5,475 prescriptions
Company payments, 2025
$591
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teh-Li T Huo was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 1,320 times for 12 patients. In total Teh-Li T Huo billed 6,104 services in 48 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 1,320 | 12 | $2.33 | $3,076 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 648 | 355 | $11.92 | $7,725 |
| 99214 Office E&M - Established | Office | 373 | 285 | $76.94 | $29K |
| 99215 Office E&M - Established | Office | 321 | 175 | $123.69 | $40K |
| 80053 Clinical Chemistry | Office | 314 | 199 | $10.08 | $3,166 |
| 85027 Blood Count | Office | 299 | 203 | $6.18 | $1,849 |
| 99233 Hospital E&M - Subsequent | Facility | 299 | 122 | $89.23 | $27K |
| 83735 Clinical Chemistry | Office | 289 | 174 | $6.45 | $1,865 |
| 99232 Hospital E&M - Subsequent | Facility | 277 | 96 | $56.10 | $16K |
| 83970 Clinical Chemistry | Office | 218 | 131 | $39.51 | $8,613 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 179 | 62 | $48.27 | $8,640 |
| 84100 Clinical Chemistry | Office | 150 | 90 | $4.55 | $682 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 142 | 62 | $36.95 | $5,247 |
| 36415 Venipuncture Blood Collection | Office | 135 | 100 | $5.88 | $794 |
| 84156 Clinical Chemistry | Office | 106 | 58 | $3.44 | $364 |
By year: 2022 $209K for 4,468 services; 2023 $183K for 4,518 services; 2024 $220K for 6,104 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 314 | 199 | $10.08 | $3,166 |
| 85027 Blood Count | 299 | 203 | $6.18 | $1,849 |
| 83735 Clinical Chemistry | 289 | 174 | $6.45 | $1,865 |
| 83970 Clinical Chemistry | 218 | 131 | $39.51 | $8,613 |
| 84100 Clinical Chemistry | 150 | 90 | $4.55 | $682 |
| 36415 Venipuncture Blood Collection | 135 | 100 | $5.88 | $794 |
| 84156 Clinical Chemistry | 106 | 58 | $3.44 | $364 |
| 82570 Clinical Chemistry | 101 | 53 | $4.84 | $489 |
| 84550 Clinical Chemistry | 91 | 57 | $4.43 | $403 |
| 85025 Blood Count | 74 | 71 | $7.34 | $543 |
Medicare prescription drug claims, 2024
In 2024, the drug Teh-Li T Huo prescribed most often to Medicare patients was Spironolactone, with 905 prescriptions and refills. In total Teh-Li T Huo wrote 5,475 Medicare prescriptions that cost $342K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 905 | 2,611 | 302 | $8,606 |
| Amlodipine Besylate Generic | 717 | 2,086 | 233 | $4,310 |
| Chlorthalidone Generic | 388 | 1,124 | 121 | $8,736 |
| Allopurinol Generic | 208 | 602 | 61 | $2,374 |
| Rosuvastatin Calcium Generic | 160 | 479 | 51 | $1,537 |
| Torsemide Generic | 158 | 435 | 76 | $3,713 |
| Eplerenone Generic | 133 | 380 | 48 | $21K |
| Losartan Potassium Generic | 117 | 344 | 44 | $1,139 |
| Metoprolol Tartrate Generic | 108 | 298 | 33 | $766 |
| Metoprolol Succinate Generic | 106 | 299 | 37 | $1,180 |
| Metformin Hcl Generic | 97 | 278 | 31 | $944 |
| Atorvastatin Calcium Generic | 95 | 237 | 27 | $578 |
| Carvedilol Generic | 88 | 252 | 35 | $817 |
| Bisoprolol Fumarate Generic | 88 | 253 | 29 | $3,105 |
| Levothyroxine Sodium Generic | 78 | 191 | 22 | $1,104 |
Brand drugs: - claims; generic drugs: 5,116 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teh-Li T Huo $591 ($591 in general payments such as food, travel and fees) from 14 companies. The largest payer was Vantive US Healthcare LLC with $149.
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 1 | $149 |
| Amgen Inc. AMGN | 5 | $89.98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63.3 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $49.39 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.9 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.61 |
| Ardelyx, Inc. ARDX | 1 | $28.26 |
| Novo Nordisk Inc NVO | 1 | $25.35 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $23.83 |
| Recordati_rare_diseases_inc. | 1 | $22.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.